CHA 2 DS 2 ‐ VASc Score as a Predictor for Atrial Fibrillation Recurrence and Clinical Outcomes Following Pulmonary Vein Isolation
Annals of Noninvasive Electrocardiology · 2025-05 · 30 (3)
DOI: 10.1111/anec.70088 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Annals of Noninvasive Electrocardiology, online erschienen am 08.05.2025. Verfasst von Mustafa Gabarin und 14 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Department, Meir Medical Center, Kfar-Saba and Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel. Hauptthemen laut MEDLINE: Atrial Fibrillation, Pulmonary Veins, Catheter Ablation, Electrocardiography. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Atrial fibrillation ( AF ) is the most common sustained cardiac arrhythmia in adults, associated with serious cardiovascular complications such as ischemic stroke, heart failure, and myocardial infarction. Pulmonary vein isolation ( PVI ) is an established rhythm‐control strategy for AF . Although the CHA 2 DS 2 ‐ VASc score is primarily used to estimate stroke risk in patients with AF , its potential utility in predicting AF recurrence after PVI has not been fully explored in contemporary, real‐world multicenter settings.
Aim
To evaluate the association between the CHA 2 DS 2 ‐ VASc score and both AF recurrence and adverse clinical outcomes following PVI .
Methods
We conducted a retrospective cohort study using the Israeli Catheter Ablation Registry ( ICAR ), including 860 patients undergoing their first PVI for AF . Patients were grouped by CHA 2 DS 2 ‐ VASc score (0–1, 2–4, > 5). The primary endpoint was AF recurrence within 12 months. Secondary endpoints included re‐hospitalization, major adverse cardiovascular events ( MACE ), and all‐cause mortality.
Results
AF recurrence occurred in 32% of patients. Recurrence rates were 25.7%, 31.4%, and 51% across the low, intermediate, and high CHA 2 DS 2 ‐ VASc score groups, respectively. A higher score was independently associated with increased recurrence risk ( HR = 2.88; 95% CI , 1.75–4.74; p < 0.001). Elevated CHA 2 DS 2 ‐ VASc scores also correlated with higher MACE and re‐hospitalization rates. No significant difference in all‐cause mortality was observed.
Conclusion
The CHA 2 DS 2 ‐ VASc score is an independent predictor of AF recurrence and adverse outcomes after PVI . Its simplicity, availability, and routine use make it a clinically useful tool to support preprocedural risk stratification in AF patients undergoing ablation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiology Department, Meir Medical Center, Kfar-Saba and Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.
- Eyal Ofer Heart Hospital, Cardiac Electrophysiology and Pacing, Rambam Health Care Campus, Haifa, Israel.
- Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
- Cardiology Department, Baruch Padeh Medical Center, the Azrieli Faculty of Medicine in the Galilee, Bar-Ilan University, Safed, Israel.
- Heart Institute, Sheba Medical Center, Tel-Hashomer, Israel and Sackler School of Medicine, Tel Aviv, Israel.
- Jesselson Integrated Heart Center, Shaare Zedek Medical Center and Hebrew University, Jerusalem, Israel.
ORCID-Profile: Mustafa Gabarin
Zitieren
APA
Gabarin, M., Suleiman, M., Elias, A., Marai, I., Beinart, R., Nof, E., Michowitz, Y., Glikson, M., Konstantino, Y., Haim, M., Luria, D., Pereg, D., Laish-Farkash, A., Omelchenko, A., & Israeli Working Group on Pacing Electrophysiology (2025). CHA 2 DS 2 ‐ VASc Score as a Predictor for Atrial Fibrillation Recurrence and Clinical Outcomes Following Pulmonary Vein Isolation. Annals of Noninvasive Electrocardiology, 30(3). https://doi.org/10.1111/anec.70088
Vancouver
Gabarin M, Suleiman M, Elias A, Marai I, Beinart R, Nof E, et al. CHA 2 DS 2 ‐ VASc Score as a Predictor for Atrial Fibrillation Recurrence and Clinical Outcomes Following Pulmonary Vein Isolation. Annals of Noninvasive Electrocardiology. 2025;30(3). doi:10.1111/anec.70088
BibTeX
@article{Gabarin2025,
author = {Gabarin, Mustafa and Suleiman, Mahmoud and Elias, Adi and Marai, Ibrahim and Beinart, Roy and Nof, Eyal and Michowitz, Yoav and Glikson, Michael and Konstantino, Yuval and Haim, Moti and Luria, David and Pereg, David and Laish-Farkash, Avishag and Omelchenko, Alexander and Israeli Working Group on Pacing Electrophysiology, Israeli Working Group on Pacing Electrophysiology},
title = {CHA 2 DS 2 ‐ VASc Score as a Predictor for Atrial Fibrillation Recurrence and Clinical Outcomes Following Pulmonary Vein Isolation},
journal = {Annals of Noninvasive Electrocardiology},
year = {2025},
volume = {30},
number = {3},
doi = {10.1111/anec.70088}
}
EUVIMED